3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Thyroid Neoplasms
1
Neoplasm Metastasis
1
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
1
Interventions
pembrolizumab
29
Cisplatin
19
Carboplatin
13
Cetuximab
12
Radiotherapy
10
Surveys and Questionnaires
9
Paclitaxel
9
Docetaxel
6
Radiotherapy, Intensity-Modulated
5
Surgical Procedures, Operative
4
Standard of Care
4
130-nm albumin-bound paclitaxel
4
dostarlimab
3
Therapeutics
3
Nivolumab
3
Fluorouracil
3
Cyclophosphamide
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Albumin-Bound Paclitaxel
3
toripalimab
2
nimotuzumab
2
fludarabine
2
durvalumab
2
atezolizumab
2
abemaciclib
2
X-Rays
2
Taxes
2
Radiosurgery
2
Radiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Thyrotropin Alfa
×
90 days
×
Clear all
No trials found.